Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

ETR/HIGH stock hub

ETR/HIGH has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/HIGHis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

77.3M

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/HIGH

In the news

Latest news · ETR/HIGH

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E64.1

P25 12.3P50 15.7P75 20.2

Trailing P/En/a

P25 16.4P50 20.9P75 30.4

ROE-0.2

P25 -6.7P50 8.5P75 17.2

ROIC-0.1

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/HIGH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

146

Groups with data

Currency

EUR

Showing 146 of 146 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	7
Employees Change	0.25%
Employees Change Percent	3.7
Enterprise value	EUR 77.1M
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Last refreshed	2026-05-10
Market cap	EUR 77.3M
Price	EUR 6.2
Price currency	EUR
Rev Per Employee	279,221.29x
Sector	Healthcare
Sic	2834
Symbol	etr/HIGH
Website	https://www.cantourage.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.12%
EV Earnings	-807.38x
EV/Sales	39.46x
Forward P/E	64.14x
P/B ratio	1.74x
P/S ratio	39.56x
PE Ratio3 Y	600.37x
PE Ratio5 Y	3,619.86x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-2.49%
Gross margin	100%
Gross Profit	EUR 2M
Gross Profit Growth	-10.97%
Gross Profit Growth Q	-22.63%
Gross Profit Growth3 Y	5.54%
Gross Profit Growth5 Y	1.29%
Net Income	EUR -95,526
Net Income Growth Q	-82.86%
Pretax Margin	-3.17%
Profit Margin	-4.89%
Profit Per Employee	EUR -13,647
ROA	-0.07
ROCE	-0.11
ROE	-0.22
ROIC	-0.11

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	27.59%
Cagr3y	-16.16%
Revenue Growth	-8.13x
Revenue Growth Q	-22.63x
Revenue Growth3 Y	5.54x
Revenue Growth5 Y	-17.82x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.04
Assets	EUR 45.5M
Cash	EUR 188,286
Current Assets	EUR 3.5M
Current Liabilities	EUR 468,007
Equity	EUR 44.4M
Interest Coverage	-3.66
Liabilities	EUR 1.1M
Long Term Assets	EUR 42M
Long Term Liabilities	EUR 632,755
Net Cash	EUR 188,286
Net Cash By Market Cap	EUR 0.24
Net Cash Growth	-30.06%
Net Debt Equity	EUR -0
Tangible Book Value	EUR 44.4M
WACC	3.64

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.53
Net Working Capital	EUR 2.9M
Quick ratio	6.69
Working Capital	EUR 3.1M
Working Capital Turnover	EUR 0.54

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	27.57%
200-day SMA	3.93
3Y total return	-41.06%
50-day SMA	5.17
50-day SMA vs 200-day SMA	50over200
All Time High	40.5
All Time High Change	-84.69%
All Time High Date	2022-11-14
All Time Low	2.32
All Time Low Change	167.24%
All Time Low Date	2025-11-26
ATR	0.27
Beta	-0.11
Beta1y	0.22
Beta2y	0.35
Ch YTD	82.89
High	6.2
High52	6.76
High52 Date	2025-06-06
High52ch	-8.28%
Low	6.04
Low52	2.32
Low52 Date	2025-11-26
Low52ch	167.24%
Ma50ch	19.83%
Price vs 200-day SMA	57.96%
RSI	68.13
RSI Monthly	49.95
RSI Weekly	72.26
Sharpe ratio	0.64x
Sortino ratio	1.11
Tr YTD	82.89
Tr1m	32.48%
Tr1w	4.03%
Tr3m	55%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -48,723
Operating Income Growth Q	-78.9
Operating margin	-2.49

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares Institutions	0.4%
Shares Out	12,470,000

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	8,390.1x
Ch1m	32.48
Ch1w	4.03
Ch1y	27.57
Ch3m	55
Ch3y	-41.06
Ch6m	103.9
Change	4.03%
Change From Open	1.64
Close	5.96
Days Gap	2.35
Dollar Volume	13,373.4
Earnings Date	2026-05-15
EBIT	EUR -48,723
F Score	1
Fiscal Year End	December
Founded	2,019
Income Tax	EUR 33,544
Is Primary Listing	1
Last Earnings Date	2025-10-31
Last Report Date	2025-06-30
Ma150	3.94
Ma150ch	57.32%
Ma20	5.54
Ma20ch	11.95%
Next Earnings Date	2026-05-15
Open	6.1
Position In Range	100
Price Date	2026-05-08
Ptbv Ratio	1.74
Relative Volume	0.27x
Revenue	1,954,549x
Tax By Revenue	1.72x
Tr6m	103.95%
Volume	2,157
Z Score	35.31

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ETR/HIGH pay a dividend?

Capital-return profile for this ticker.

Performance

ETR/HIGH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/HIGH?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.4%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

ETR/HIGH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

68.1

Neutral momentum band

Price vs 200-day MA

+58.0%

50/200-day relationship not available

Beta (5Y)

-0.11

Less volatile than the market

Sharpe ratio

0.64

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/HIGH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/HIGH stock rating?

etr/HIGH is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/HIGH analysis?

The full report lives at /stocks/etr/HIGH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/HIGH?

The latest report frames etr/HIGH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/HIGH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.